Perflutren Lipid Microsphere Articles
Point Bio starts Ph III trial of contrast agent
19 August 2002
DuPont's Definity filed in EU
23 September 1999
DuPont Files For Ultrasound Agent
16 December 1998
Showing 1-6 of 6 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
